Sign in with your email address username.

×

[Department of Error] Department of Error

Cox TM, Drelichman G, Cravo R, et al. Eliglustat compared with imiglucerase in patients with Gaucher’s disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial. Lancet 2015; 385: 2355–62—In supplemental table C in the appendix, the first column and second row should have read “Imiglucerase (N=45)”, the third column and 11th row should have read “–0·10 (1·07)”, the second column and 12th row should have read “–0·47 (1·29)”, the third column and 13th row should have read “0·13 (1·03)”, and the second column and 14th row should have read “–0·18 (1·12)”.

email